Literature DB >> 11287331

Acidification and glucocorticoids independently regulate branched-chain alpha-ketoacid dehydrogenase subunit genes.

X Wang1, J M Chinsky, P A Costeas, S R Price.   

Abstract

Acidification or glucocorticoids increase the maximal activity and subunit mRNA levels of branched chain alpha-ketoacid dehydrogenase (BCKAD) in various cell types. We examined whether these stimuli increase transcription of BCKAD subunit genes by transfecting BCKAD subunit promoter-luciferase plasmids containing the mouse E2 or human E1alpha-subunit promoter into LLC-PK(1) cells, which do not express glucocorticoid receptors, or LLC-PK(1)-GR101 cells, which we have engineered to constitutively express the glucocorticoid receptor gene. Dexamethasone or acidification increased luciferase activity in LLC-PK(1)-GR101 cells transfected with the E2 or E1alpha-minigenes; acidification augmented luciferase activity in LLC-PK(1) cells transfected with these minigenes but dexamethasone did not. A pH-responsive element in the E2 subunit promoter was mapped to a region >4.0 kb upstream of the transcription start site. Dexamethasone concurrently stimulated E2 subunit promoter activity and reduced the binding of nuclear factor-kappaB (NF-kappaB) to a site in the E2 promoter. Thus acidification and glucocorticoids independently enhance BCKAD subunit gene expression, and the glucocorticoid response in the E2 subunit involves interference with NF-kappaB, which may act as a transrepressor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11287331     DOI: 10.1152/ajpcell.2001.280.5.C1176

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  6 in total

1.  Regulation of hepatic branched-chain α-ketoacid dehydrogenase complex in rats fed a high-fat diet.

Authors:  Yoshihiro Kadota; Takanari Toyoda; Yasuyuki Kitaura; Sean H Adams; Yoshiharu Shimomura
Journal:  Obes Res Clin Pract       Date:  2013-12       Impact factor: 2.288

2.  Decreased miR-29 suppresses myogenesis in CKD.

Authors:  Xiaonan H Wang; Zhaoyong Hu; Janet D Klein; Liping Zhang; Fude Fang; William E Mitch
Journal:  J Am Soc Nephrol       Date:  2011-09-30       Impact factor: 10.121

3.  Cerebral Oedema, Blood-Brain Barrier Breakdown and the Decrease in Na(+),K(+)-ATPase Activity in the Cerebral Cortex and Hippocampus are Prevented by Dexamethasone in an Animal Model of Maple Syrup Urine Disease.

Authors:  Luciana Rosa; Leticia S Galant; Dhébora M Dall'Igna; Janaina Kolling; Cassiana Siebert; Patrícia F Schuck; Gustavo C Ferreira; Angela T S Wyse; Felipe Dal-Pizzol; Giselli Scaini; Emilio L Streck
Journal:  Mol Neurobiol       Date:  2015-07-02       Impact factor: 5.590

Review 4.  Animal models of maple syrup urine disease.

Authors:  K J Skvorak
Journal:  J Inherit Metab Dis       Date:  2009-03-09       Impact factor: 4.982

5.  MicroRNA-29 induces cellular senescence in aging muscle through multiple signaling pathways.

Authors:  Zhaoyong Hu; Janet D Klein; William E Mitch; Liping Zhang; Ivan Martinez; Xiaonan H Wang
Journal:  Aging (Albany NY)       Date:  2014-03       Impact factor: 5.682

6.  miR-26a Limits Muscle Wasting and Cardiac Fibrosis through Exosome-Mediated microRNA Transfer in Chronic Kidney Disease.

Authors:  Bin Wang; Aiqing Zhang; Haidong Wang; Janet D Klein; Lin Tan; Ze-Mu Wang; Jie Du; Nawazish Naqvi; Bi-Cheng Liu; Xiaonan H Wang
Journal:  Theranostics       Date:  2019-03-07       Impact factor: 11.556

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.